• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Consumer Cyclical·BN.PA
Share

Danone S.A. Stocks

€ 60.92Last Updated 16.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

€ 45.73B

€ 60.92
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

18.09.2026 19:00

Shares of the owner of KitKat and Nespresso fell after it lost control of its assets in Russia

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Danone S.A. is a major company within the food and beverage industry, conducting its operations across various global regions including Europe, North America (Noram), Latin America, Asia Pacific, Africa, and the Middle East. The company's business is organized into three principal segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Under its Essential Dairy & Plant-Based division, Danone manufactures and distributes a broad array of products. This range includes yogurts, diverse milk products, coffee creamers, a variety of drinks and beverages, plant-based alternatives, ice creams, desserts, and powdered nutritional protein items. These are sold under proprietary brands such as Actimel, Activia, Alpro, Danette, Danio, and Danonino, as well as licensed brands including International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition segment focuses on providing tailored nutritional offerings. This encompasses products developed for pregnant and breastfeeding mothers, infants, and young children, marketed under names like Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics. Additionally, this segment extends to medical nutrition, featuring tube feeding formulas (e.g., Nutrison), oral nutritional supplements (e.g., Fortimel, NutriDrink), and specialized hypoallergenic products for children with allergies (e.g., Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo). Within the Waters segment, Danone offers a portfolio of bottled water products, some of which are enhanced with natural fruit extracts, fruit juice, and vitamins. Key brands in this category include evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj. Danone distributes its wide selection of products through multiple channels. These include large retail chains, traditional market outlets, convenience stores, healthcare settings such like hospitals, clinics, and pharmacies, and increasingly, through e-commerce platforms. Incorporated in 1899, the company was initially known as Groupe Danone before officially changing its name to Danone S.A. in April 2009. Its corporate headquarters are situated in Paris, France.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of BN.PA is 84.3 and suggests 38.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

18.09.2026 20:06

Goldman Sachs expects corporate profit growth to slow. Why isn't it worried about a bubble?

18.09.2026 19:23

"The whole 'Terminator' thing is nonsense": An investor from *The Short Game* on the threat of AI

18.09.2026 19:00

Shares of the owner of KitKat and Nespresso fell after it lost control of its assets in Russia

18.09.2026 18:37

Strategists have issued their most optimistic forecast for European stocks since 2018

18.09.2026 17:49

Shares of a small biotech company soared after the U.S. approved its gene therapy. Who else stands to benefit?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026